Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Daily volatility influences return paths and allocation choices. This primer covers interpretation and practical tweaks to targets and expectations.
25,212 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
When a stock plunges, it’s easy to blame the hype. This week, planet labs stock plummeting has investors weighing ear...
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
An institutional investor disclosed a new $6.5 million stake in Middleby. This article uncovers what’s behind that be...
AFC Gamma investors are watching the Q1 2026 earnings call closely. This guide breaks down what to expect, how to rea...
Nike stands as a global powerhouse, but recent pressure has investors asking, should Nike stock? This guide lays out ...
Vanguard’s 8-for-1 split lowered VGT’s price, letting smaller investors pursue income strategies through covered call...
Canadian Solar's Q4 2025 results set the stage for 2025. This deep dive explains what to watch, the margin trajectory...
June brought a notable move in the tech pocket as D-Wave Quantum jumped after a price-target boost from Mizuho. This ...
Chart Industries just delivered a sweeping earnings milestone, but a sizable investor trimmed a multi-million dollar ...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
Today’s market moved in Ford’s favor as analysts primed optimism around Ford’s energy initiatives alongside its tradi...